Philips Respironics announced a recall for sleep apnea machine models that may increase the risk of developing lung cancer, kidney cancer, liver cancer, and other forms of cancer. The affected products include continuous positive airway pressure (CPAP) machines, Bilevel positive airway pressure (BiPAP) machines, and mechanical ventilators designed to help people with breathing disorders, including sleep apnea. The U.S. Food and Drug Administration (FDA) identified the Philips Respironics recall as the agency’s most serious (Class I).
The Philips recall affects millions of people who rely on these machines to help them with breathing disorders. According to Philips, roughly 80% of the affected products are CPAP machines for people with sleep apnea. Shocked by the news that these products may be linked to cancer and a host of other serious health issues, many are turning to the courts to seek damages against Philips for putting a defective and dangerous product on the market.
CPAP Settlement Update 2024
August 23, 2024: We have important announcements regarding the Philips Respironics Settlement agreement.
To participate in the CPAP personal injury settlement program, claimants must have been included on an Identification Order Declaration of Primary Counsel and Eligible Claimant List with a Qualifying Injury on or before June 21, 2024. Claimants must also have been retained as a client by an attorney on or before April 29, 2024.
Unrepresented eligible claimants may participate if they have filed a CPAP lawsuit alleging a qualifying injury in the MDL Court or Massachusetts Court or submitted an Identification Order Declaration with a qualifying injury on or before June 21, 2024. You can read about qualifying injuries and who is considered an eligible claimant in the master settlement agreement.
To receive compensation from the CPAP settlement, all eligible claimants must submit a Registration Packet on or before December 10, 2024.
June 11, 2024: Over 790 CPAP lawsuits are pending in the multidistrict litigation alleging injuries related to recalled Philips breathing machines. If the proposed settlement from earlier this year is not approved, bellwether trials in the MDL could take place in 2025 before U.S. District Judge Joy Flowers Conti.
May 1, 2024: Philips announced a personal injury settlement worth nearly $1.1 billion to resolve lawsuits involving its CPAP machines, which were the subject of a large-scale recall in 2021. The settlement will compensate individuals in the U.S. who filed lawsuits against the company, alleging the defective breathing machines caused harm. The company announced it would also pay an additional $25 million for medical monitoring as part of the settlement.
Philips did not admit to fault or liability for any injuries alleged in the medical device lawsuits. Following the announcement, Philips experienced a surge in its stock value in response to the settlement news and its first-quarter financial results.
The settlement excludes a previous $600 million settlement to compensate affected device owners. Philips is offering $100 for each recalled device for consumers still possessing the affected machines. Affected CPAP owners have until August 9, 2024 to pursue a claim.
The announced settlement is not yet final. Payments are expected to be disbursed to those who filed lawsuits in 2025.
September 13, 2023: Last week, Philips Respironics agreed to a partial CPAP settlement worth approximately $479 million to settle class action claims regarding flaws in the company's CPAP breathing machines. The CPAP settlement specifically addresses monetary reimbursements for device users and vendors who financed replacements, with no cap on economic claims that can be made. This means that other CPAP users may be able to qualify for compensation.
The agreement does not cover other claims related to personal injuries or medical expenses resulting from the use of the machines. Those claims will be litigated separately. Some legal experts believe the personal injury and wrongful death cases could be worth billions.
Under the terms of the CPA class action settlement announced last week, affected consumers will receive compensation ranging from approximately $50 to $1,500. Additionally, Philips will provide $100 for each device returned. The company has revealed that as of September 2023, it has already replaced and delivered nearly 2.5 million devices to U.S. consumers and suppliers.
Philips has been the subject of public scrutiny for failing to promptly inform consumers about the potential flaws in their CPAP breathing machines. Records show that concerns were raised within the company as early as 2015. The FDA has received over 105,000 reports of injuries and 385 reports of deaths possibly linked to the foam degradation in Philips CPAP machines.
What Caused the Philips CPAP Recall?
Philips Respironics cited a serious problem with the polyester-based polyurethane foam that dampens the sound and vibration when the machines are in use. The foam can break down and release small chemical particles into the machine’s airway, which can then be inhaled or ingested. According to the FDA, particulate exposure from Philips sleep apnea machines may have “toxic or carcinogenic effects to organs, such as kidneys and liver.”
CPAP Class Action Lawyers
If you or someone in your family developed cancer after using any of the Philips Respironics CPAP machines, BiPAP machines, or ventilators listed below, you may be eligible to pursue justice and compensation in a lawsuit against the manufacturer. CPAP lawyers represent victims on a contingency fee basis, which means the attorneys only get paid if your case ends in a successful verdict or settlement. If for some reason the litigation does not result in compensation, you would not owe anything.
To learn more about your legal rights and see if you qualify for a CPAP lawsuit, fill out our case evaluation form below or call us at (310) 207-3233.
Which CPAP Machines Did Philips Recall?
According to the U.S. Food and Drug Administration (FDA), the following Philips CPAP machines, BiPAP machines, and ventilators have been recalled:
Recalled CPAP and BiPAP Products:
- C-Series ASV
- C-Series S/T and AVAPS
- Dorma 400
- Dorma 500
- DreamStation
- DreamStation ASV
- DreamStation Go
- DreamStation ST, AVAPS
- E30 (Emergency Use Authorization)
- OmniLab Advanced+
- REMstar SE Auto
- SystemOne (Q-Series)
- SystemOne ASV4
Recalled Ventilators:
- A-Series BiPAP A30
- A-Series BiPAP A40
- A-Series BiPAP Hybrid A30*
- A-Series BiPAP V30 Auto
- Garbin Plus, Aeris, LifeVent
- Trilogy 100
- Trilogy 200
*not marketed in the U.S.
Why Are CPAP Sleep Apnea Machines Recalled?
Philips determined a recall was appropriate after receiving user reports and conducting lab testing on several CPAP, BiPAP, and ventilators, including the widely-used Philips DreamStation. The company found that the polyester-based polyurethane (PE-PUR) sound abatement foam used in Philips sleep machines can degrade and deteriorate over time, which can cause people who rely on these machines for breathing assistance to inhale or ingest small particles or gas.
Inhaling or ingesting PE-PUR particulate can cause a host of health issues. Philips has already acknowledged that the risks of particulate exposure include:
- Adverse effects to kidneys and liver
- Asthma
- Headache
- Inflammatory response
- Irritation (eye, respiratory tract, and skin)
- Respiratory issues
- Toxic carcinogenic effects
According to Philips, the foam degradation may worsen in certain conditions, including higher temperatures and humidity, and the use of unapproved cleaning methods (including ozone).
If you are interested in learning more about pursuing a lawsuit against Philips, contact us today or call (310) 207-3233. Our class action attorneys offer free and confidential CPAP lawsuit case evaluations.
